[1]
“Rigorous Bivariate Synthesis of Benefit-Risk Profiles for Direct Oral Anticoagulants in Atrial Fibrillation”, ST, vol. 2, no. 2, Apr. 2026, Accessed: Jul. 30, 2026. [Online]. Available: https://synthesis-medicine.org/index.php/journal/article/view/12